Clinical Trials from The University of Texas Health Science Center at Houston

Studies available for: Rheumatology

See a study that interests you? Contact that study's coordinator for more information on how to participate.

Study Information:

Study Title:SCOT Study

Study Location:Houston, TX

Facility Name:University of Texas Health Science Center

Study Description:A Randomized, Open-Label, Phase II/III Multicenter Study of High-Dose Immunosuppressive Therapy Using Total Body Irradiation, Cyclophosphamide, ATGAM, and Autologous Transplantation with Auto-CD34+HPC Versus Intravenous Pulse Cyclophosphamide for the Treatment of Severe Systemic Sclerosis

HSC Number:HSC-MS-04-399

Funding Agency/Source:NIH, NIAID

Subject Information:

Subject Age Range:18 - 65 years

Inclusion/Exclusion Criteria:1. SSc defined by American College of Rheumatology criteria 2. Modified Rodnan skin score score of >16 3. Duration of SSc < 4 years from first non-Raynaud's symptom 4. 1 of the following: SSc-related pulmonary disease or History of renal crisis or disease, not active at the time of screening

Study Coordinator(s) Information:

Name:Marcia Kerr RN

E-mail:Marcia.L.Kerr@uth.tmc.edu

Phone Number:713-500-7118

Principal Investigator Information:

Name:Maureen Mayes, MD, MPH

Study Information:

Study Title:Lymphatic Function Study

Study Location:Houston, TX

Facility Name:Memorial Hermann Hospital

Study Description:The purpose of this research is to determine the effect of an automated massage device on lymphatic flow in persons with lymphedema of either one arm or one leg. 12 subjects are needed.

More Information:website

HSC Number:HSC-IMM-08-0401

Funding Agency/Source:National Institutes of Health

Subject Information:

Subject Age Range:At least 18 years of age

Inclusion/Exclusion Criteria:Lymphedema in one arm or leg Women of childbearing potential must not be pregnant or breastfeeding, and birth control must be used for one month after study participation Ability to lie on the back for 60 minutes Not allergic to iodine Weight less than 400 lbs No eczema, rash, scarring, or tattoos at injection sites

Study Coordinator(s) Information:

Name:Jessica Nollkamper

E-mail:jessica.nollkamper@uth.tmc.edu

Phone Number:713-500-3561

Principal Investigator Information:

Name:Eva M. Sevick